High prevalence of vitamin K and D deficiency and decreased BMD in inflammatory bowel disease
- 562 Downloads
Vitamin K and D deficiency and decreased bone mineral density (BMD) were highly prevalent in patients with inflammatory bowel disease (IBD), especially Crohn’s disease (CD). Dietary intakes of these vitamins, however, were above the Japanese adequate intakes in IBD patients, suggesting that malabsorption is the basis for hypovitaminosis K and D and decreased BMD.
We have studied the possible involvement of vitamin K and D deficiency in the pathogenesis of decreased BMD in IBD.
Seventy patients with IBD were evaluated for their BMD; plasma levels of vitamin K; phylloquinone (PK), menaquinone-7 (MK-7), and 25OH-D; serum PTH, protein induced by vitamin K absence (PIVKA-II), and undercarboxylated osteocalcin (ucOC) levels; and their food intake.
Compared with ulcerative colitis (UC) patients, CD patients had significantly lower plasma vitamin K and 25OH-D concentrations; significantly higher serum levels of PTH, PIVKA-II, and ucOC; and significantly lower BMD scores at almost all measurement sites. More IBD patients were vitamin K deficient in bone than in liver. Multiple regression analyses revealed that low plasma concentrations of vitamin K and 25OH-D were independent risk factors for low BMD and that they were associated with the patients’ fat intake, but not with their intake of these vitamins.
IBD patients have high prevalence of decreased BMD and vitamin K and D deficiency probably caused by malabsorption of these vitamins.
KeywordsInflammatory bowel disease Malabsorption Vitamin K Vitamin D
This study was supported by the Health and Labor Science Research Grant entitled “Studies on the Dietary Reference Intakes (Recommended Dietary Allowance) for Japanese” (principal investigator, Professor Katsumi Shibata, The University of Shiga Prefecture, Shiga, Japan) from the Ministry of Health, Labor and Welfare, Japan.
Conflicts of interest
- 21.Bikle DD (2001) Osteoporosis in gastrointestinal, pancreatic, and hepatic diseases. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. 2nd edn. Academic, San Diego, CA, pp 237–258Google Scholar
- 24.Krasinsk SD, Russell RM, Furie BC et al (1985) The prevalence of vitamin K deficiency in chronic gastrointestinal disorders. Am J Clin Nutr 41:639–643Google Scholar
- 28.Davies M, Berry JL, Mee AP (2005) Bone disorders associated with gastrointestinal and hepatobiliary disease. In: Feldman D, Pike JW, Glorieux FG (eds) Vitamin D. 2nd edn. Academic, San Diego CA, pp 1293–1311Google Scholar
- 30.Ministry of Health, Labour, and Welfare, Japan (2005) Dietary reference intakes for Japanese. Daiichi Shuppan, TokyoGoogle Scholar
- 33.Sambrook PN (2006) Glucocorticoid-induced osteoporosis. In: Favus MJ (ed) (2006) Primers on the metabolic bone diseases and disorders of mineral metabolism. 6th edn. American Society for Bone and Mineral Research, Washington DC, pp 296–302Google Scholar